DUBLIN, Sept. 30, 2022 /PRNewswire/ -- The "Laboratory Animal Models, 3D Cultures and Organoids: Global Markets" report has been added to
ResearchAndMarkets.com's offering.
The report describes three global markets: the animal models market, the 3D cultures market and the organoids market. The organoids market especially is described in more detail, with market estimation for different segments in a separate chapter of the report.
The fast growth rate of the kidney segment is attributed to growing adoption of kidney organoids, which results from their exceptional ability, derived from the use of disease-specific human pluripotent stem cells (hPSCs), to reproduce human diseases caused by genetic alterations. This has helped to usher in the next generation of kidney disease models. 26 data tables and 28 additional tables
An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market Estimation of the actual market size and market forecast for organoids in USD million values, and their corresponding market share analysis by product type, application, and geographic region
Regional and country specific data and analysis for organoids in the U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, Australia, China and India etc.
Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and also for evaluating the safety and metabolism of chemical compounds
Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
Review of selected patents and patent applications on organoids, and emerging developments in the global market
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Chapter 2 Summary and Highlights
Chapter 3 Animal Model Market Technology Background Methods of Animal Model and 3D Cell Culture Modification
Physical and Chemical Mutations
Common Species of Laboratory Animals
Chapter 4 Impact of Covid-19 on the Global Market for Organoids Chapter 5 Market Dynamics
Increasing Emphasis on Developing Alternative Approaches to Animal Testing
Rising Demand for Tumor Modelling and Biobanking to Drive Market Growth Increasing Adoption of the Organoid Technology for Wide Range of Applications
Stringent Government Regulatory Setting in Research and Development of Cell Cultures and Stem Cells
Concerns Associated With the Integration of Organoids into Current Workflows
Increasing Applications of Organoids in Drug Development, Personalized Medicine and Transplantational Medicine
Chapter 6 3D Cell Technology Background
2D Cultures Vs. 2.5D Cultures Vs. 3D Cultures
Scaffold-Based and Scaffold-Free 3D Cell Cultures
Scaffold-Free 3D Cell Cultures
Scaffold-Based 3D Cell Cultures
Tissue Engineering and Bioprinting
Types of Bioprinting Methods
Types of Organ-On-Chip Devices
Chapter 7 Market Breakdown by Organ Type
Chapter 8 Market Breakdown by Application
Drug Toxicity and Efficacy Testing
Chapter 9 Market Breakdown by Region
Chapter 10 Patent Review/New Developments
Chapter 11 Analysis of Market Opportunities
Market Opportunities: 3D Cell Culture Segment
Advantages and Disadvantages of 3D Cell Cultures and Animal Models 3D Cell Cultures in General Chapter 12 Competitive Landscape
Chapter 13 Profiles of Companies and Important Institutions
Labcorp Drug Development (Covance Inc.)
Bioprinting and Regenerative Medicine Companies
East River Biosolutions/Xylyx Bio
Cincinnati Children's Hospital Medical Center
Hubrecht Organoid Technology (Hub)
Other 3D Cell Culture Companies
For more information about this report visit https://www.researchandmarkets.com/r/hkllu3
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg